MFN is reshaping global pharma pricing. The real challenge is not price reduction, but controlling how value propagates across markets. This paper explains how leading organizations are redesigning their commercial systems to protect global asset value.

Welcome Aleksandar Ruzicic as Stratence Partners' new SVP! Over 30 years of healthcare consulting expertise. Exciting times ahead!

Welcome Gary Kieffer as Stratence Partners' new SVP! Over 30 years of healthcare consulting expertise. Exciting times ahead!

Roz Lawson.Expertise that transforms strategy into success. 30+ years in pharma, biotech, and medical products, driving growth & excellence.